Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Scientists at Emory University publish new data on breast cancer
August 7th, 2008
According to recent research published in the journal Applied Immunohistochemistry & Molecular Morphology, "Survivin is a novel inhibitor of apoptosis commonly detected in tissues during fetal development and in cancer, but not Usually in normal tissues. It has been suggested that the expression of this protein may be of prognostic significance in gastric, colorectal, and bladder carcinomas." "We assessed survivin expression in breast carcinomas correlating results with expression of other antiapoptotic (bcl-2, bcl-x) and proapoptotic (bax) markers, with prognostic parameters, and with prognosis. Paraffin-embedded sections of 37 breast carcinomas were...
Source: Women's Health Weekly (2008-08-07)
|
